# OnCo record neotorch (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/neotorch/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "neotorch", "NCT04158440" ;
  schema:name "Neotorch"@en ;
  schema:alternateName "NEOTORCH"@en ;
  schema:description "A Chinese trial showing that adding the PD-1 antibody toripalimab to chemotherapy before and after lung cancer surgery more than doubles the time before the cancer comes back."@en ;
  schema:url <https://onco.cc/trials/neotorch/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04158440>, <https://doi.org/10.1001/jama.2023.24735> ;
  onco:status "positive" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/resectable-nsclc/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/>, <https://onco.cc/technologies/cytotoxic-chemotherapy/>, <https://onco.cc/technologies/platinum/> ;
  onco:targets <https://onco.cc/targets/pd1/> ;
  onco:drugs <https://onco.cc/drugs/toripalimab/>, <https://onco.cc/drugs/cisplatin/>, <https://onco.cc/drugs/carboplatin/> ;
  onco:companies <https://onco.cc/companies/junshi/> ;
  onco:terms <https://onco.cc/terms/neoadjuvant-adjuvant/>, <https://onco.cc/terms/major-pathological-response/>, <https://onco.cc/terms/pcr/> ;
  onco:trials <https://onco.cc/trials/keynote-671/>, <https://onco.cc/trials/nct03800134/>, <https://onco.cc/trials/nct04025879/>, <https://onco.cc/trials/nct04379635/> .